BAYONET trial: A multicenter phase II trial of staged combination with encorafenib plus binimetinib plus cetuximab following encorafenib plus cetuximab in patients with BRAFV600E-mutant metastatic colorectal cancer.

被引：0
|
作者：
Matsubara, Yuki
Bando, Hideaki
Kotani, Daisuke
Kagawa, Yoshinori
Harada, Kazuaki
Osumi, Hiroki
Izawa, Naoki
Kawakami, Takeshi
Boku, Shogen
Matsumoto, Toshihiko
Wakabayashi, Masashi
Yoshino, Takayuki
机构：
[1] Aichi Canc Ctr Hosp, Dept Clin Oncol, Nagoya, Aichi, Japan
[2] Natl Canc Ctr Hosp East, Dept Gastroenterol & Gastrointestinal Oncol, Kashiwa, Chiba, Japan
[3] Osaka Gen Med Ctr, Dept Surg Gastroenterol, Osaka, Japan
[4] Hokkaido Univ Hosp, Dept Gastroenterol & Hepatol, Sapporo, Hokkaido, Japan
[5] Japanese Fdn Canc Res, Canc Inst Hosp, Dept Gastroenterol, Tokyo, Japan
[6] St Marianna Univ, Dept Clin Oncol, Sch Med, Kawasaki, Kanagawa, Japan
[7] Shizuoka Canc Ctr, Div Gastrointestinal Oncol, Shizuoka, Japan
[8] Kansai Med Univ Hosp, Canc Treatment Ctr, Osaka, Japan
[9] Natl Canc Ctr Hosp East, Div Promot Drug & Diagnost Dev, Kashiwa, Chiba, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
TPS271
引用
收藏
页码：TPS271 / TPS271
页数：1
相关论文
共 50 条
  • [1] Encorafenib plus cetuximab in patients with BRAFV600E-mutated metastatic colorectal cancer - Polish multicenter experience
    Radecka, Barbara
    [J]. ONCOLOGY IN CLINICAL PRACTICE, 2024, 20 (04): : 308 - 308
  • [2] Encorafenib plus cetuximab in patients with BRAFV600E-mutated metastatic colorectal cancer - Polish multicenter experience
    Gelej, Marek
    Zajac, Patryk
    Dabrowska, Maria
    Drejws-Watrobska, Anna
    Galinska, Bogumila
    Galus, Lukasz
    Gwozdz-Cieslik, Agnieszka
    Hetman, Katarzyna
    Kawecki, Maciej
    Malik, Mateusz
    Streb, Joanna
    Wierzbicka, Katarzyna
    Wiosek, Piotr
    Radecka, Barbara
    [J]. ONCOLOGY IN CLINICAL PRACTICE, 2024, 20 (04): : 264 - 269
  • [3] Updated results of the BEACON CRC safety lead-in: Encorafenib (ENCO) plus binimetinib (BIM) plus cetuximab (CETUX) for BRAFV600E-mutant metastatic colorectal cancer (mCRC).
    Kopetz, Scott
    Grothey, Axel
    Yaeger, Rona
    Cuyle, Pieter-Jan A. R.
    Huijberts, Sanne
    Schellens, Jan H. M.
    Elez, Elena
    Fakih, Marwan
    Viladot, Clara Montagut
    Peeters, Marc
    Desai, Jayesh
    Yoshino, Takayuki
    Ciardiello, Fortunato
    Wasan, Harpreet Singh
    Maharry, Kati
    Christy-Bittel, Janna
    Gollerkeri, Ashwin
    Van Cutsem, Eric
    Tabernero, Josep
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (04)
  • [4] ANCHOR CRC: Results From a Single-Arm , Phase II Study of Encorafenib Plus Binimetinib and Cetuximab in Previously Untreated BRAFV600E-Mutant Metastatic Colorectal Cancer
    Van Cutsem, Eric
    Taieb, Julien
    Yaeger, Rona
    Yoshino, Takayuki
    Grothey, Axel
    Maiello, Evaristo
    Elez, Elena
    Dekervel, Jeroen
    Ross, Paul
    Ruiz-Casado, Ana
    Graham, Janet
    Kato, Takeshi
    Ruffinelli, Jose C.
    Andre, Thierry
    Roussel, Edith Carriere
    Klauck, Isabelle
    Groc, Melanie
    Vedovato, Jean-Claude
    Tabernero, Josep
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (14) : 2628 - +
  • [5] Encorafenib, binimetinib and cetuximab combined therapy for patients with BRAFV600E mutant metastatic colorectal cancer
    Huijberts, Sanne C. F. A.
    van Geel, Robin M. J. M.
    Bernards, Rene
    Beijnen, Jos H.
    Steeghs, Neeltje
    [J]. FUTURE ONCOLOGY, 2020, 16 (06) : 161 - 174
  • [6] Mutational profiles associated with resistance in patients with BRAFV600E mutant colorectal cancer treated with cetuximab and encorafenib plus /- binimetinib or alpelisib
    Huijberts, Sanne C. F. A.
    Boelens, Mirjam C.
    Bernards, Rene
    Opdam, Frans L.
    [J]. BRITISH JOURNAL OF CANCER, 2021, 124 (01) : 176 - 182
  • [7] Safety of encorafenib, binimetinib, plus cetuximab for Japanese patients with BRAF V600E metastatic colorectal cancer
    Yamaguchi, Toshifumi
    Daisuke, Kotani
    Atsuo, Takashima
    Takeshi, Kato
    Toshiki, Masuishi
    Yoshito, Komatsu
    Manabu, Shiozawa
    Taito, Esaki
    Naoki, Izawa
    Shinji, Takeuchi
    Hideaki, Bando
    Satoru, Iwasa
    Hiroko, Hasegawa
    Taroh, Satoh
    Hiroya, Taniguchi
    Takayuki, Yoshino
    [J]. ANNALS OF ONCOLOGY, 2022, 33 : S479 - S479
  • [8] Adverse Events Associated with Encorafenib Plus Cetuximab in Patients with BRAFV600E-mutant Metastatic Colorectal Cancer: An in-depth Analysis of the BEACON CRC Study
    Taieb, Julien
    Lonardi, Sara
    Desai, Jayesh
    Folprecht, Gunnar
    Gallois, Claire
    Marques, Eduardo Polo
    Khan, Sadya
    Castagne, Claire
    Wasan, Harpreet
    [J]. CLINICAL COLORECTAL CANCER, 2023, 22 (01) : 59 - 66
  • [9] Binimetinib, encorafenib and cetuximab (BEACON Trial) combination therapy for patients with BRAF V600E-mutant metastatic colorectal cancer
    Shahjehan, F.
    Kamatham, S.
    Chandrasekharan, C.
    Kasi, P. M.
    [J]. DRUGS OF TODAY, 2019, 55 (11) : 683 - 693
  • [10] Safety and Efficacy of Encorafenib, Binimetinib, and Cetuximab for BRAFV600E-Mutant Metastatic Colorectal Cancer: Results of the Japanese Expanded Access Program
    Kotani, Daisuke
    Takashima, Atsuo
    Kato, Takeshi
    Satoh, Taroh
    Masuishi, Toshiki
    Komatsu, Yoshito
    Shiozawa, Manabu
    Esaki, Taito
    Izawa, Naoki
    Takeuchi, Shinji
    Bando, Hideaki
    Iwasa, Satoru
    Hasegawa, Hiroko
    Yamaguchi, Toshifumi
    Taniguchi, Hiroya
    Ushida, Yasunori
    Oizaki, Toshiya
    Inoue, Chiaki
    Yoshino, Takayuki
    [J]. CLINICAL COLORECTAL CANCER, 2024, 23 (02)
12345